RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
BLOOD
Collezione AO Ordine Mauriziano

Items : 31

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Cavo M; Baccarani M; Rosti G; Tenti E; Laginestra MA; Pileri SA; Percesepe A; Mignone F; Vigneri P; Saglio G; Pane F; Errichiello S; Serra A; Stella S; Calistri E; Annunziata M; Bocchia M; Musolino C; Attolico I; Coluzzi S; Capodanno I; Girasoli M; Sancetta R; Salvucci M; Binotto G; Abruzzese E; D'Adda M; di Bona E; di Raimondo F; et alii...

Predictive Factors for Overall Survival in Chronic Myeloid Leukemia Patients: An Analysis By the Gimema Cml Italian Study in Blood

2020
AOU Città della Salute di Torino
AO Ordine Mauriziano

Ciccone G; Saglio G; Pane F; Foà R; Baccarani M; Martino B; Luciano L; Pizzuti M; Gozzini A; Scortechini AR; Albano F; Bergamaschi M; Capodanno I; Patriarca A; Fava C; Rege Cambrin G; Sorà F; Galimberti S; Bocchia M; Binotto G; Reddiconto G; Guarini A; Maggi A; Sanpaolo G; De Candia MS; Giai V; Abruzzese E; Miggiano MC; Falzetti F; et alii...

Low circulating B lymphocytes in newly diagnosed follicular and diffuse large B cell lymphoma: Differences compared to normal subjects and possible prognostic role in Blood

2017
AO Ordine Mauriziano

Bruna R; Geuna M; Scalabrini DR; Cignetti A; Santoro N; Gottardi D; Passera R; Tarella C;

Molecular definition of activated B cell-like (ABC) DLBCL identifies patients who may benefit from front-line intensive R-HDS chemotherapy with ASCT in Blood

2017
AO Ordine Mauriziano

Melle F; Motta G; Fabbri M; Tabanelli V; Calleri A; Bruna R; Derenzini E; Corsini C; Tarella C; Gianni AM; Rambaldi A; Cesano A; Pileri SA;

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. in Blood / Blood. 2015 Jan 22;125(4):600-5. doi: 10.1182/blood-2014-05-576157. Epub 2014 Dec 12.

2015
AO Ordine Mauriziano

Bodini M; Ronchini C; Giacò L; Russo A; Melloni GE; Luzi L; Sardella D; Volorio S; Hasan SK; Ottone T; Lavorgna S; Lo-Coco F; Candoni A; Fanin R; Toffoletti E; Iacobucci I; Martinelli G; Cignetti A; Tarella C; Bernard L; Pelicci PG; Riva L;

The hypoxia-inducible factor-1alpha is constitutively upregulated in TP53 disrupted CLL cells: A potential target to overcome fludarabine resistance in Blood

2015
AO Ordine Mauriziano
ASL Asti

Griggio V; Vitale C; Riganti C; Kopecka J; Dal Bo M; Rossi D; Pozzato G; Laurenti L; Zallio F; Marchetti M; Ruggeri M; Omedè P; Del Poeta G; Gattei V; Gaidano G; Boccadoro M; Massaia M; Coscia M;

Life expectancy in follicular lymphoma is mainly determined by response to first LINE treatment: A LONG-TERM survey on 597 patients in Blood

2015
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Barbui AM; Bruna R; Caracciolo D; Gottardi D; Gritti G; Passera R; Ramadan S; Rossi A; Rambaldi A;

Whole body magnetic resonance imaging with diffusion weighted imaging is a valuable alternative to contrast-enhanced computed tomography for the initial staging in Hodgkin's and non-Hodgkin's lymphoma in Blood

2014
AO Ordine Mauriziano

Balbo-Musetto A; Bruna R; Gueli A; Saviolo C; Petracchini M; Gottardi D; De Crescenzo A; Cirillo S; Tarella C;

Normal circulating B cells are markedly reduced in follicular lymphoma and diffuse large B cell lymphoma at diagnosis in Blood

2014
AO Ordine Mauriziano

Geuna M; Riccardo B; Cignetti A; Santoro N; Gueli A; Elia AR; Prato G; De Rosa G; Papotti M; Tarella C;

Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-related apoptosis-inducing ligand (TRAIL) in Blood

2013
AO Ordine Mauriziano

Buttiglieri S; Carlo-Stella C; Spatola T; Pulito R; Naldini L; Anichini A; Magni M; Giacomini A; Tarella C; Gianni AM;

Primary refractory disease in non-Hodgkin's lymphoma: A retrospective study on 3,952 newly diagnosed patients undergoing first-line chemotherapy in Blood

2012
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Rossi A; Barbui AM; Gritti G; Caracciolo D; Hu H; Gottardi D; Passera R; Rambaldi A;

The peripheral blood lymphocyte to monocyte ratio at diagnosis is a potent outcome predictor in diffuse large B-cell lymphoma treated with R-CHOP: A long-term analysis on 973 patients receiving chemotherapy with or without rituximab in Blood

2012
AO Ordine Mauriziano

Rambaldi A; Boschini C; Delaini F; Oldani E; Rossi A; Barbui AM; Gritti G; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Gianni AM; Tarella C;

Molecular and functional analysis of peripheral lymphocytes in churg strauss syndrome reveals several monoclonal expansions of CD8+ cells with a Th1/proinflammatory profile in Blood

2012
AO Ordine Mauriziano

Boita M; Circosta P; Guida G; Elia AR; Heffler E; Geuna M; Tarella C; Rolla G; Cignetti A;

Intensified chemo-immunotherapy including up-front autologous or allogeneic stem cell transplantation (SCT) for young patients with newly diagnosed peripheral T-cell lymphomas: Final results of a phase II multicenter prospective clinical trial in Blood

2012
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Parvis G; Salvi F; Bruno B; Baldini L; Patti C; Milone G; Ferreri AJM; Tarella C; Pileri SA; Dodero A;

Long telomere length of white blood cells following umbilical cord blood transplant (UCBT): Is hematopoiesis younger in UCBT recipients compared to healthy age-matched controls? in Blood

2012
AO Ordine Mauriziano

Tarella C; Risso A; Spatola T; Ruella M; Milone G; Pioltelli P; Iori AP; Di Bartolomeo P; Rambaldi A; Bacigalupo AP; Arcese W;

Cellular composition and clonal evolution of 295 type III PNH clones: An italian multi-laboratory study in Blood

2012
AO Ordine Mauriziano

Cannizzo E; Susca D; Triolo AM; Lo Pardo C; Buccisano F; Tedone E; Messana F; Oliva BM; Ottaviano V; Carulli G; Monti F; De Propris MS; Stacchini A; Vanelli L; Perbellini O; Arpinati M; Viola N; Gervasi F; Conte CA; Tanca D; Lanza F; Geuna M; Del Vecchio L;

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib- melphalanprednisone (VMP) in untreated multiple myeloma patients with renal impairment in Blood

2011
AO Ordine Mauriziano

Morabito F; Gentile M; Mazzone C; Rossi D; Di Raimondo F; Bringhen S; Ria R; Offidani M; Patriarca F; Nozzoli C; Petrucci MT; Benevolo G; Vincelli I; Guglielmelli T; Grasso M; Marasca R; Baldini L; Montefusco V; Musto P; Cascavilla N; Majolino I; Musolino C; Cavo M; Boccadoro M; Palumbo A;

Rituximab followed by involved fields radiotherapy (IF-RT) in stage I-II follicular lymphoma (FL): Long term results in Blood

2011
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ruella M; Filippi A; Russo ADI; Caracciolo D; Matteucci P; Magni M; Di Nicola M; Ricardi U; Montefusco V; Parvis G; Tarella C; Gianni AM; Devizzi L;

Early and permanent telomere shortening in bone marrow-derived cells following chemotherapy: A parallel study in vivo in lymphoma patients and in vitro in cultured mesenchymal stem cells in Blood

2011
AO Ordine Mauriziano

Gueli A; Ruella M; Risso A; Spatola T; Hu HJ; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Safety, tolerability and activity of ofatumumab, bendamustine and dexamethasone combination as first-line treatment of mantle-cell lymphoma in the elderly: A multicenter study in Blood

2011
AO Ordine Mauriziano

Magni M; Di Nicola M; Carlo-Stella C; Devizzi L; Guidetti A; Matteucci P; Viviani S; Zambelli S; Ferreri AJM; Rambaldi A; Di Raimondo F; Tarella C; Gallamini A; Nobile F; Vallisa D; Carella AM; Patti C; Quarta G; Rizzoli V; Benedetti F; Corradini P; Gianni AM;

A phase II study of the HDAC inhibitor givinostat in combination with hydroxyurea in patients with polycythemia vera resistant to hydroxyurea monotherapy in Blood

2011
AO Ordine Mauriziano

Rambaldi A; Finazzi G; Vannucchi AM; Martinelli V; Rodeghiero F; Nobile F; Specchia G; Pogliani EM; Olimpieri OM; Fioritoni G; Musolino C; Saglio G; Sivera P; Barosi G; Di Tollo S; Barbui T;

Retargeting of citokine-induced killer (CIK) cells with molecularly engrafted T-cell receptors (TCR): A preclinical in vitro and in vivo study in Blood

2011
AO Ordine Mauriziano

Elia AR; Inghirami G; Circosta P; Cristofani F; Santoro N; Sangiolo D; Tarella C; Cignetti A;

Pre-operative cytokine-induced mobilization of bone marrow-derived cells, followed by revascularization surgery: Early and long-term results of a prospective study in patients with end-stage ischemic cardiac disease in Blood

2011
AO Ordine Mauriziano

Actis Dato GM; Sansone F; Zingarelli E; Flocco R; Punta G; Parisi F; Forsennati PG; Bardi GL; Ponte SD; Casabona R; Tarella C;

A CD8+ T-cell clone directed against AML blasts that recognizes a tumor specific antigen expressed also by solid tumors in Blood

2010
AO Ordine Mauriziano

Elia AR; Circosta P; Vincenzo R; Mele L; Allione B; Tarella C; Cignetti A;

Telomere length in Ph - Negative chronic myeloproliferative neoplasms: It is reduced according to JAK2 V617F mutation allele burden and it is not affected by cytoreductive treatment with hydroxyurea in Blood

2010
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Carobbio A; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A;

Male gender, quality of grafted cells, advanced age, rituximab and radiotherapy are the main factors that variously influence the occurrence of secondary malignancies following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) survey in 1,347 lymphoma patients in Blood

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Benedetti F; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Mule A; Crocchiolo R; Bosa M; Barbui A; Di Nicola M; Caracciolo D; Sorio M; Gianni AM; Rambaldi A;

Bortezomib, melphalan, prednisone and thalidomide (VMPT) followed by maintenance with bortezomib and thalidomide for initial treatment of elderly multiple myeloma patients in Blood

2009
AO Ordine Mauriziano
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Rossi D; Ria R; Offidani M; Patriarca F; Nozzoli C; Levi A; Guglielmelli T; Benevolo G; Callea V; Olivero B; Morabito F; Grasso M; Marasca R; Rizzo M; Pia Falcone A; Gottardi D; Montefusco V; Musolino C; Zambello R; Cangialosi C; Pietrantuono G; Magarotto V; Petrucci MT; Musto P; Ciccone G; Di Raimondo F; Gaidano G; et alii...

Dexamethasone, cytarabine and cisplatin or oxaliplatin schedule (DHAP or OX-DHA) is effective and widely applicable in chronic lymphocytic leukemia and waldenström macroglobulinemia in Blood

2009
AO Ordine Mauriziano

Ruella M; Ricca I; Gueli A; Gottardi D; Caracciolo D; Bergui L; Gavarotti P; De Crescenzo A; Farina L; Corradini P; Tarella C;

High response rate with favorable survival projections in high-risk patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP-14 or early intensified chemotherapy with rituximab and autograft (R-HDS): Results of the interim analysis of a gitil prospective multicenter phase III study in Blood

2009
AO Ordine Mauriziano

Cortelazzo S; Tarella C; Gianni AM; Ladetto M; Zanni M; Corradini P; Di Nicola M; Patti C; Mulè A; Majolino I; Billio A; Gueli A; Di Raimondo F; Chiarenza A; Gallamini A; Ferreri A; Pizzolo G; Benedetti F; La Nasa G; Leoni P; Gini G; Trentin L; Rodeghiero F; Marchioli R; Barbui T; Barbui A; Rambaldi A;

Preliminary results of a phase II trial with the multikinase inhibitor sorafenib in heavily pretreated patients with relapsed/refractory non-Hodgkin lymphoma (NHL) in Blood

2009
AO Ordine Mauriziano

Guidetti A; Carlo-Stella C; Devizzi L; Matteucci P; Marchianò A; Lanocita R; Magni M; Dodero A; Tarella C; Di Nicola M; Corradini P; Gianni AM;

CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. in Blood / Blood. 2003 Mar 1;101(5):1962-9. doi: 10.1182/blood-2002-05-1339. Epub 2002 Oct 24.

2003
AO Ordine Mauriziano

Granziero L; Circosta P; Scielzo C; Frisaldi E; Stella S; Geuna M; Giordano S; Ghia P; Caligaris-Cappio F;